The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients.
Diabetes Care
; 24(5): 953-4, 2001 May.
Article
in En
| MEDLINE
| ID: mdl-11347762
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiazoles
/
Endothelial Growth Factors
/
Lymphokines
/
Thiazolidinediones
/
Diabetes Mellitus, Type 2
/
Hypoglycemic Agents
/
Metformin
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Diabetes Care
Year:
2001
Document type:
Article
Country of publication:
Estados Unidos